Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study.
Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi SA, Tavakoli Shiraji S, Azari M, Shafaroudi P, Vaezi M. Azari M, et al. Among authors: bahri t. Front Oncol. 2024 Feb 21;14:1339605. doi: 10.3389/fonc.2024.1339605. eCollection 2024. Front Oncol. 2024. PMID: 38454927 Free PMC article.
Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the COVID-19 Pandemic: An Iranian Consensus.
Mousavi SA, Rad S, Rostami T, Vaezi M, Fumani HK, Babakhani D, Shiraji ST, Barkhordar M, Bahri T, Asl AH, Kiumarsi A, Janbabaei G. Mousavi SA, et al. Among authors: bahri t. Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020050. doi: 10.4084/MJHID.2020.050. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32670528 Free PMC article. No abstract available.
Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience.
Barkhordar M, Kasaeian A, Janbabai G, Mousavi SA, Fumani HK, Tavakoli S, Bahri T, Ghavamzadeh A, Vaezi M. Barkhordar M, et al. Among authors: bahri t. Leuk Res. 2022 Sep;120:106918. doi: 10.1016/j.leukres.2022.106918. Epub 2022 Jul 12. Leuk Res. 2022. PMID: 35843087
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M, Chahardouli B, Biglari A, Ahmadvand M, Bahri T, Alaeddini F, Sharifi Aliabadi L, Noorani SS, Bagheri Amiri F, Biglari M, Shemshadi MR, Ghavamzadeh A, Vaezi M. Barkhordar M, et al. Among authors: bahri t. Front Immunol. 2023 Apr 19;14:1169666. doi: 10.3389/fimmu.2023.1169666. eCollection 2023. Front Immunol. 2023. PMID: 37153556 Free PMC article.
Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience.
Tavakoli Shiraji S, Rostami MR, Kamranzadeh Foumani H, Mousavi SA, Vaezi M, Rad S, Babakhani D, Barkhordar M, Bahri T, Janbabaei G, Malekmohammadi A, Mohammadi S, Mansouri V. Tavakoli Shiraji S, et al. Among authors: bahri t. Int J Hematol Oncol Stem Cell Res. 2023 Jul 1;17(3):156-166. doi: 10.18502/ijhoscr.v17i3.13305. Int J Hematol Oncol Stem Cell Res. 2023. PMID: 37817970 Free PMC article.
Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study.
Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi SA, Tavakoli Shiraji S, Azari M, Shafaroudi P, Vaezi M. Azari M, et al. Among authors: bahri t. Front Oncol. 2024 Apr 18;14:1397607. doi: 10.3389/fonc.2024.1397607. eCollection 2024. Front Oncol. 2024. PMID: 38699637 Free PMC article.
Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation.
Barkhordar M, Kasaeian A, Tavakoli S, Vaezi M, Kamranzadeh Foumani H, Bahri T, Babakhani D, Mirzakhani L, Mousavi A, Mousavi SA, Ghavamzadeh A. Barkhordar M, et al. Among authors: bahri t. Int J Hematol Oncol Stem Cell Res. 2021 Jan 1;15(1):51-60. doi: 10.18502/ijhoscr.v15i1.5249. Int J Hematol Oncol Stem Cell Res. 2021. PMID: 33613900 Free PMC article.
16 results